DT-PACE regimen: Difference between revisions

	WikiDoc Resources for DT-PACE regimen
Articles
Most recent articles on DT-PACE regimen Most cited articles on DT-PACE regimen Review articles on DT-PACE regimen Articles on DT-PACE regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on DT-PACE regimen Images of DT-PACE regimen Photos of DT-PACE regimen Podcasts & MP3s on DT-PACE regimen Videos on DT-PACE regimen
Evidence Based Medicine
Cochrane Collaboration on DT-PACE regimen Bandolier on DT-PACE regimen TRIP on DT-PACE regimen
Clinical Trials
Ongoing Trials on DT-PACE regimen at Clinical Trials.gov Trial results on DT-PACE regimen Clinical Trials on DT-PACE regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on DT-PACE regimen NICE Guidance on DT-PACE regimen NHS PRODIGY Guidance FDA on DT-PACE regimen CDC on DT-PACE regimen
Books
Books on DT-PACE regimen
News
DT-PACE regimen in the news Be alerted to news on DT-PACE regimen News trends on DT-PACE regimen
Commentary
Blogs on DT-PACE regimen
Definitions
Definitions of DT-PACE regimen
Patient Resources / Community
Patient resources on DT-PACE regimen Discussion groups on DT-PACE regimen Patient Handouts on DT-PACE regimen Directions to Hospitals Treating DT-PACE regimen Risk calculators and risk factors for DT-PACE regimen
Healthcare Provider Resources
Symptoms of DT-PACE regimen Causes & Risk Factors for DT-PACE regimen Diagnostic studies for DT-PACE regimen Treatment of DT-PACE regimen
Continuing Medical Education (CME)
CME Programs on DT-PACE regimen
International
DT-PACE regimen en Espanol DT-PACE regimen en Francais
Business
DT-PACE regimen in the Marketplace Patents on DT-PACE regimen
Experimental / Informatics
List of terms related to DT-PACE regimen

VisualWikitext

Revision as of 20:26, 12 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:Dexamethasone-Thalidomide-Platinol-Adriamycin-Cytoxan-Etoposide Regimen; DT-PACE Regimen

Overview

DT-PACE regimen refers to a regimen consisting of dexamethasone, thalidomide (DT) and cisplatin, doxorubicin, cyclophosphamide and etoposide (PACE) used for the treatment of relapsed and refractory multiple myeloma.^[1]

Regimen

DDexamethasone

TThalidomide

PCisplatin

ADoxorubicin (Adriamycin)

CCyclophosphamide

EEtoposide

Indications

Relapsed and refractory multiple myeloma^[2]

References

[1] "NCI Thesaurus".

[2] "NCI Thesaurus".

[1]

[2]

@@ Line 6: / Line 6: @@
 ==Overview==
-{{PAGENAME}} refers to a regimen consisting of dexamethasone, thalidomide (DT) and cisplatin, doxorubicin, cyclophosphamide and etoposide (PACE) used for the treatment of relapsed and refractory [[multiple myeloma]].<ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63501}}</ref>
+{{PAGENAME}} refers to a regimen consisting of [[dexamethasone]], [[thalidomide]] (DT) and [[cisplatin]], [[doxorubicin]], [[cyclophosphamide]] and [[etoposide]] (PACE) used for the treatment of relapsed and refractory [[multiple myeloma]].<ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63501}}</ref>
 ==Regimen==
 {{chemo|D|Dexamethasone}}
 {{chemo|T|Thalidomide}}
 {{chemo|P|Cisplatin}}
 {{chemo|A|Doxorubicin (Adriamycin)}}